Vincerx Pharma, Inc. (VINC)
NASDAQ: VINC · Real-Time Price · USD
0.2756
-0.2674 (-49.24%)
At close: Apr 9, 2025, 4:00 PM
0.2652
-0.0104 (-3.77%)
Pre-market: Apr 10, 2025, 9:01 AM EDT
Vincerx Pharma Stock Forecast
VINC's stock price has decreased by -99.71% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Vincerx Pharma stock has a target of 40, which predicts an increase of 14,413.79% from the current stock price of 0.28.
Analyst Consensus: Buy
* Price targets were last updated on Oct 8, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for Vincerx Pharma is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 2 | 2 | 2 | 2 | 2 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Leerink Partners | Leerink Partners | Buy Maintains $80 → $40 | Buy | Maintains | $80 → $40 | +14,413.79% | Oct 8, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Apr 9, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Apr 1, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $100 | Buy | Reiterates | $100 | +36,184.47% | Sep 7, 2023 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $80 → $60 | Strong Buy | Maintains | $80 → $60 | +21,670.68% | Nov 17, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-12.24
from -15.85
EPS Next Year
-0.58
from -12.24
Revenue Forecast
Revenue | 2025 | 2026 |
---|---|---|
High | n/a | 231,000 |
Avg | n/a | 224,400 |
Low | n/a | 215,600 |
Revenue Growth
Revenue Growth | 2025 | 2026 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
EPS Forecast
EPS | 2025 | 2026 |
---|---|---|
High | -12.60 | -0.60 |
Avg | -12.24 | -0.58 |
Low | -11.76 | -0.56 |
EPS Growth
EPS Growth | 2025 | 2026 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.